Gossamer Bio to Announce Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call and Webcast on February 25, 2021Business Wire • 02/19/21
Gossamer Bio to Host Webcast Focused on its Inflammatory Bowel Disease Program, GB004, on February 18, 2021Business Wire • 02/04/21
Gossamer Bio to Host Webcast Focused on GB002 and Pulmonary Arterial Hypertension (PAH) on December 15, 2020Business Wire • 12/07/20
Gossamer Bio Announces Appointment of Faheem Hasnain as Chief Executive OfficerBusiness Wire • 11/16/20
Gossamer Bio, Inc. (GOSS) CEO Sheila Gujrathi on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/11/20
Gossamer Bio Announces Third Quarter 2020 Financial Results and Provides Corporate UpdateBusiness Wire • 11/10/20
Gossamer Bio to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 10, 2020Business Wire • 11/06/20
Gossamer Bio Announces GB1275 Data Presentations at 2020 Society for Immunotherapy of Cancer Annual MeetingBusiness Wire • 11/06/20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic RhinosinusitisBusiness Wire • 10/13/20
Gossamer Bio Announces Presentation of GB004 Phase 1b Clinical Data at United European Gastroenterology Virtual Week 2020 and Additional Program UpdatesBusiness Wire • 10/12/20
Gossamer Bio Announces GB004 Data Presentations at United European Gastroenterology Virtual Week 2020Business Wire • 10/09/20
Are Options Traders Betting on a Big Move in Gossamer Bio (GOSS) Stock?Zacks Investment Research • 09/30/20
Gossamer Bio Announces Data Presentations at the Virtual European Respiratory Society International Congress 2020Business Wire • 09/07/20
Gossamer Bio Announces Second Quarter 2020 Financial Results and Provides Corporate UpdateBusiness Wire • 08/11/20
Gossamer Bio Announces Data Presentations at the American Thoracic Society 2020 Virtual ConferenceBusiness Wire • 08/05/20
GOSSAMER DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Gossamer Bio, Inc. To Contact The FirmPRNewsWire • 05/20/20
Gossamer Bio, Inc. (GOSS) CEO Sheila Gujrathi on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/13/20